Luz M. Ramirez

1.1k total citations · 1 hit paper
10 papers, 832 citations indexed

About

Luz M. Ramirez is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Luz M. Ramirez has authored 10 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Internal Medicine, 4 papers in Cardiology and Cardiovascular Medicine and 2 papers in Surgery. Recurrent topics in Luz M. Ramirez's work include Venous Thromboembolism Diagnosis and Management (6 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Migraine and Headache Studies (2 papers). Luz M. Ramirez is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (6 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Migraine and Headache Studies (2 papers). Luz M. Ramirez collaborates with scholars based in United States, Canada and Denmark. Luz M. Ramirez's co-authors include Alexander Gallus, Graham F. Pineo, Michael R. Lassen, Dalei Chen, Gary E. Raskob, Susan Solymoss, Mark N. Levine, Howard A. Liebman, David Deitchman and Chu‐Shu Gu and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Luz M. Ramirez

8 papers receiving 799 citations

Hit Papers

Apixaban versus Enoxaparin for Thromboprophylaxis after H... 2010 2026 2015 2020 2010 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement
    2010 583 citations Michael R. Lassen, Alexander Gallus et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luz M. Ramirez United States 6 719 669 165 91 73 10 832
Marjolein Brekelmans Netherlands 14 476 0.7× 368 0.6× 165 1.0× 83 0.9× 108 1.5× 19 628
C. Falgá Spain 12 557 0.8× 426 0.6× 152 0.9× 152 1.7× 88 1.2× 20 643
H Decousus France 6 577 0.8× 380 0.6× 246 1.5× 178 2.0× 86 1.2× 15 660
Carlo Bova Italy 12 696 1.0× 461 0.7× 215 1.3× 100 1.1× 72 1.0× 32 861
A. Planès France 10 653 0.9× 496 0.7× 335 2.0× 51 0.6× 75 1.0× 23 760
Francisco Humberto de Abreu Maffei Brazil 11 284 0.4× 176 0.3× 147 0.9× 79 0.9× 183 2.5× 37 550
A. Sampériz Spain 9 529 0.7× 432 0.6× 138 0.8× 102 1.1× 96 1.3× 17 576
Pablo Javier Marchena Spain 11 314 0.4× 235 0.4× 119 0.7× 106 1.2× 61 0.8× 24 383
K Myers United States 5 331 0.5× 222 0.3× 141 0.9× 61 0.7× 102 1.4× 7 420
Joanne McGinnis Canada 6 293 0.4× 275 0.4× 111 0.7× 38 0.4× 80 1.1× 7 395

Countries citing papers authored by Luz M. Ramirez

Since Specialization
Citations

This map shows the geographic impact of Luz M. Ramirez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luz M. Ramirez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luz M. Ramirez more than expected).

Fields of papers citing papers by Luz M. Ramirez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luz M. Ramirez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luz M. Ramirez. The network helps show where Luz M. Ramirez may publish in the future.

Co-authorship network of co-authors of Luz M. Ramirez

This figure shows the co-authorship network connecting the top 25 collaborators of Luz M. Ramirez. A scholar is included among the top collaborators of Luz M. Ramirez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luz M. Ramirez. Luz M. Ramirez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
Ashina, Messoud, Peter McAllister, Charly Gaul, et al.. (2025). Rimegepant for acute treatment of migraine in triptan-unsuitable adults: A randomized, double-blind, placebo-controlled phase 4 trial. Cephalalgia. 45(11). 2235440354–2235440354.
3.
Levine, Mark N., Chu‐Shu Gu, Howard A. Liebman, et al.. (2012). A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer. Journal of Thrombosis and Haemostasis. 10(5). 807–814. 158 indexed citations
4.
Pineo, Graham F., Alexander Gallus, Gary E. Raskob, et al.. (2012). Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroups. Journal of Thrombosis and Haemostasis. 11(3). 444–451. 33 indexed citations
5.
Lassen, Michael R., Alexander Gallus, Gary E. Raskob, et al.. (2010). Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement. New England Journal of Medicine. 363(26). 2487–2498. 583 indexed citations breakdown →
6.
Liebman, Howard A., et al.. (2010). OC-03 Randomized phase II trial of an oral factor Xa inhibitor in patients with metastatic cancer on chemotherapy. Thrombosis Research. 125. S161–S162. 5 indexed citations
7.
8.
Levine, Mark N., David Deitchman, Howard A. Liebman, et al.. (2009). A randomized phase II trial of a new anticoagulant, apixaban, in metastatic cancer. Journal of Clinical Oncology. 27(15_suppl). e20514–e20514. 17 indexed citations
9.
Moura, Manuel Castro de, et al.. (2007). Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection. BMC Gastroenterology. 7(1). 31–31. 32 indexed citations
10.
Ramirez, Luz M., Teresa L. Carman, Susan M. Begelman, et al.. (2005). Bivalirudin in Patients with HIT or Clinically Suspected HIT.. Blood. 106(11). 918–918. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marjolein Brekelmans Breakdown of academic impact, for papers by C. Falgá Breakdown of academic impact, for papers by H Decousus Breakdown of academic impact, for papers by Carlo Bova Breakdown of academic impact, for papers by A. Planès Breakdown of academic impact, for papers by Francisco Humberto de Abreu Maffei Breakdown of academic impact, for papers by A. Sampériz Breakdown of academic impact, for papers by Pablo Javier Marchena Breakdown of academic impact, for papers by K Myers Breakdown of academic impact, for papers by Joanne McGinnis
Rankless by CCL
2026